MaxCyte partners with Apeiron for siRNA immunotherapy 22-Jul-2020 By Ben Hargreaves MaxCyte and Apeiron enter agreement for the use of engineering equipment for the development of a cell therapy.
Kite collaborates to increase efficiency of CAR-T manufacture 07-Mar-2019 By Ben Hargreaves MaxCyte announces a partnership with Kite to explore the use of flow electroporation technology to enable the non-viral cell engineering of CAR-T drug candidates.